SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001171843-17-003885
Filing Date
2017-06-29
Accepted
2017-06-29 17:00:35
Documents
11
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 40-F f40f_062817.htm 40-F 40158
2 EXHIBIT 99.1 exh_991.htm EX-99.1 383470
3 EXHIBIT 99.2 exh_992.htm EX-99.2 1467475
4 EXHIBIT 99.3 exh_993.htm EX-99.3 368818
5 EXHIBIT 99.4 exh_994.htm EX-99.4 5056
6 EXHIBIT 99.5 exh_995.htm EX-99.5 12420
7 EXHIBIT 99.6 exh_996.htm EX-99.6 4959
8 GRAPHIC image_002.jpg GRAPHIC 2781
9 GRAPHIC image_003.jpg GRAPHIC 3515
10 GRAPHIC nept_logo.jpg GRAPHIC 15160
11 GRAPHIC kpmg.jpg GRAPHIC 2374
  Complete submission text file 0001171843-17-003885.txt   2316770
Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Neptune Technologies & Bioressources Inc. (Filer) CIK: 0001401395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 40-F | Act: 34 | File No.: 001-33526 | Film No.: 17938991
SIC: 2834 Pharmaceutical Preparations